Today

Agents

Chat

Arena

Discover

More

App

Ascendis Pharma director Lars Holtug disposes of 236 shares worth $62,337.59 - ASND News | Rallies

Ascendis Pharma director Lars Holtug disposes of 236 shares worth $62,337.59

ASND•2026-09-03

Director share sale

Ascendis Pharma director Lars Holtug sold 236 ordinary shares on Sep. 2, 2026 at USD 264.13 each.
Directly held stake fell to 4,000 ordinary shares following the transaction.

Related News

Citi revises Q3 2026 Brent forecast to $86/bbl

XLE•2026-09-03

Telefônica Brasil signs G 13.5 million innovation exclusivity license deal with Telefónica Innovación Digital

VIV•2026-09-03

BWX Technologies awarded contract from DOE/NNSA to design first module of NNSA lithium processing facility

Sources

S

Ascendis Pharma director Lars Holtug disposes of 236 shares worth $62,337.59

Sec

BWXT•2026-09-03

Motiva restarts small crude distillation unit at Texas refinery, sources say

XLE•2026-09-03

US Cash Crude-US inland domestic grades firm for a second straight day

XLE•2026-09-03